EP3764988A4 - Gel-forming polypeptides - Google Patents

Gel-forming polypeptides Download PDF

Info

Publication number
EP3764988A4
EP3764988A4 EP19768400.4A EP19768400A EP3764988A4 EP 3764988 A4 EP3764988 A4 EP 3764988A4 EP 19768400 A EP19768400 A EP 19768400A EP 3764988 A4 EP3764988 A4 EP 3764988A4
Authority
EP
European Patent Office
Prior art keywords
gel
forming polypeptides
polypeptides
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19768400.4A
Other languages
German (de)
French (fr)
Other versions
EP3764988A1 (en
Inventor
Sheau Yu Teddy Hsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adepthera LLC
Original Assignee
Adepthera LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adepthera LLC filed Critical Adepthera LLC
Publication of EP3764988A1 publication Critical patent/EP3764988A1/en
Publication of EP3764988A4 publication Critical patent/EP3764988A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP19768400.4A 2018-03-15 2019-03-14 Gel-forming polypeptides Pending EP3764988A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862643593P 2018-03-15 2018-03-15
PCT/US2019/022275 WO2019178359A1 (en) 2018-03-15 2019-03-14 Gel-forming polypeptides

Publications (2)

Publication Number Publication Date
EP3764988A1 EP3764988A1 (en) 2021-01-20
EP3764988A4 true EP3764988A4 (en) 2022-04-20

Family

ID=67907279

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19768400.4A Pending EP3764988A4 (en) 2018-03-15 2019-03-14 Gel-forming polypeptides

Country Status (3)

Country Link
EP (1) EP3764988A4 (en)
CN (1) CN111885999A (en)
WO (1) WO2019178359A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3036095A1 (en) 2016-09-13 2018-03-22 Allergan, Inc. Stabilized non-protein clostridial toxin compositions
CN110818790A (en) * 2019-10-31 2020-02-21 成都圣诺生物制药有限公司 Preparation method of temeprelin
CN113577014B (en) * 2020-12-30 2023-03-24 广州图微科创生物科技有限公司 Medical apparatus and instrument, hydrogel and preparation method and application thereof
CN114181284A (en) * 2021-11-17 2022-03-15 成都赛恩贝外科学研究院 Application of nano short peptide DRF3 in medicines, NK cell carriers and biomedicine
CN114214280B (en) * 2021-12-20 2022-11-29 南开大学 Method for culturing cell spheres by using self-assembled polypeptide derivative hydrogel, cell spheres and application thereof
CN115925975A (en) * 2022-08-03 2023-04-07 山东大学 CAR-M phi in-vitro editing preparation method of targeting tumor stem cells and application thereof
WO2024039670A1 (en) 2022-08-15 2024-02-22 Dana-Farber Cancer Institute, Inc. Antibodies against cldn4 and methods of use thereof
WO2024118297A1 (en) * 2022-11-28 2024-06-06 Edwards Lifesciences Corporation Bioprosthetic tissue and prosthetic antimicrobial treatment
CN116270974B (en) * 2023-03-09 2024-03-12 湖南大学 Composition, abelmoschus delivery system and preparation method
CN117511851B (en) * 2024-01-03 2024-03-26 中国肉类食品综合研究中心 Application of hydrogel scaffold in preparation of cell culture meat

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958877A (en) * 1995-05-18 1999-09-28 Wimalawansa; Sunil J. Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide
US5998367A (en) * 1991-03-08 1999-12-07 Amylin Corporation Pramlintide pro H-amylin salts and compositions
US20050261179A1 (en) * 2002-10-04 2005-11-24 The Government Of The United States Of America Vasoregulating compounds and methods of their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60327843D1 (en) * 2002-03-04 2009-07-16 Ipsen Pharma MEDICAMENT FORMULATIONS WITH DELAYED RELEASE WITH A CARRIER PEPTIDE
KR101544245B1 (en) * 2009-02-03 2015-08-12 아뮤닉스 오퍼레이팅 인코포레이티드 Extended recombinant polypeptides and compositions comprising same
CN105079783B (en) * 2014-05-22 2018-06-19 清华大学深圳研究生院 Pharmaceutical composition and its preparation method and application
DE102015000363A1 (en) * 2015-01-20 2016-07-21 Emc Microcollections Gmbh New modular functionalizable peptide hydrogels
CN109475604B (en) * 2016-02-09 2023-04-04 艾得佩索拉公司 Dosing and use of long-acting CLR/RAMP agonists
CN107412150B (en) * 2017-07-16 2019-07-09 常州大学 A kind of preparation method of the polypeptide hydrogel for packaging medicine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998367A (en) * 1991-03-08 1999-12-07 Amylin Corporation Pramlintide pro H-amylin salts and compositions
US5958877A (en) * 1995-05-18 1999-09-28 Wimalawansa; Sunil J. Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide
US20050261179A1 (en) * 2002-10-04 2005-11-24 The Government Of The United States Of America Vasoregulating compounds and methods of their use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ELGERSMA RONALD C. ET AL: "Synthesis and structural investigations of N-alkylated [beta]-peptidosulfonamide-peptide hybrids of the amyloidogenic amylin(20-29) sequence: implications of supramolecular folding for the design of peptide-based bionanomaterials", ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 4, no. 19, 1 January 2006 (2006-01-01), pages 3587 - 3597, XP055866902, ISSN: 1477-0520, DOI: 10.1039/B606875H *
See also references of WO2019178359A1 *
SUTTER ET AL: "Recombinant gelatin hydrogels for the sustained release of proteins", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 119, no. 3, 22 May 2007 (2007-05-22), pages 301 - 312, XP022087330, ISSN: 0168-3659, DOI: 10.1016/J.JCONREL.2007.03.003 *

Also Published As

Publication number Publication date
CN111885999A (en) 2020-11-03
WO2019178359A1 (en) 2019-09-19
EP3764988A1 (en) 2021-01-20

Similar Documents

Publication Publication Date Title
EP3856764A4 (en) Masked cytokine polypeptides
EP3764988A4 (en) Gel-forming polypeptides
EP3803740A4 (en) Blockchain overwatch
EP3801265A4 (en) Uroflowmeter
EP3784463A4 (en) Fluorosulfones
EP3813861A4 (en) Heparin-associated polypeptides and uses thereof
EP3802565A4 (en) Polypeptides
EP3871913A4 (en) Mobile object
EP3721129A4 (en) Cryosphere
AU2019350356A1 (en) Arginase1 polypeptides
EP3870698A4 (en) Antipathogenic polypeptides
EP3858868A4 (en) Polypeptide composition
EP3876716A4 (en) Cryo-carrier
EP3834079A4 (en) Multi-question multi-answer configuration
EP3760901A4 (en) Sealing structure
EP3898652A4 (en) Mitochondria-targeting peptides
EP3792349A4 (en) Peptide macrocyclase
EP3791184A4 (en) Immunoreactive polypeptides
EP3787554A4 (en) Stent-graft
EP3738602A4 (en) Cytocide
EP3608631A4 (en) Compass
AU2018901430A0 (en) Modified polypeptides
AU2018904117A0 (en) Polypeptides and uses thereof
EP3822397A4 (en) Complex
AU2018101027A4 (en) PadPay

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 21/02 20060101ALI20211215BHEP

Ipc: A61K 47/42 20170101ALI20211215BHEP

Ipc: A61K 38/16 20060101ALI20211215BHEP

Ipc: A61K 9/06 20060101ALI20211215BHEP

Ipc: A61K 9/00 20060101ALI20211215BHEP

Ipc: C07K 7/06 20060101ALI20211215BHEP

Ipc: C07K 14/47 20060101ALI20211215BHEP

Ipc: C07K 14/585 20060101ALI20211215BHEP

Ipc: C07K 14/575 20060101AFI20211215BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20220321

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 21/02 20060101ALI20220315BHEP

Ipc: A61K 47/42 20170101ALI20220315BHEP

Ipc: A61K 38/16 20060101ALI20220315BHEP

Ipc: A61K 9/06 20060101ALI20220315BHEP

Ipc: A61K 9/00 20060101ALI20220315BHEP

Ipc: C07K 7/06 20060101ALI20220315BHEP

Ipc: C07K 14/47 20060101ALI20220315BHEP

Ipc: C07K 14/585 20060101ALI20220315BHEP

Ipc: C07K 14/575 20060101AFI20220315BHEP